Ozempic-maker Novo open to upgrading US listing
Boss Mike Doustdar says he sees ‘advantages’ in giving US investors direct access to Danish group’s stock
Boss Mike Doustdar says he sees ‘advantages’ in giving US investors direct access to Danish group’s stock
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Boss Mike Doustdar says he sees ‘advantages’ in giving US investors direct access to Danish group’s stock
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.
The US Centers for Medicare & Medicaid Services cancelled about 315,000 plans in August. Grouped from 2 articles across 2 sources.
Analysts say new sweeping US sanctions stand to worsen lives of millions of Iranians struggling in battered economy.
The U.S. Air Base Spangdahlem said that the pilot ejected and was receiving medical care. Grouped from 6 articles across 4 sources.
The initiative is being rolled out in about 100 countries with limited access to medical resources. Grouped from 2 articles across 1 sources.
Ukraine will get access to OpenAI's advanced GPT 5.6 Sol model under the deal - a rival to Anthropic's Mythos and Fable